HIV and Wellness Screening Being Made Accessible by Healthcare Framework EMR Software

As per UNAIDS Data 2020, South Africa has now met the first of the 90-90-90 targets, with 90% of people living with HIV aware of their status in 2018. Large-scale HIV screening programmes play a very important role in finding positive cases and referring the persons for treatment and follow-up. SABCOHA (South African Business Coalition on Health and AIDS) is currently conducting an ongoing Wellness and HIV screening initiative on selected groups and areas across the country as part of funded prevalence studies by The Global Fund.

As per UNAIDS Data 2020, South Africa has now met the first of the 90-90-90 targets, with 90% of people living with HIV aware of their status in 2018. Large-scale HIV screening programmes play a very important role in finding positive cases and referring the persons for treatment and follow-up. SABCOHA (South African Business Coalition on Health and AIDS) is currently conducting an ongoing Wellness and HIV screening initiative on selected groups and areas across the country as part of funded prevalence studies by The Global Fund.

Participants undergo HIV testing and counselling, together with screening for hypertension and diabetes. They also complete a Tuberculosis cough questionnaire, which assists as a screening tool to refer patients for further TB testing to confirm their results, should the questionnaire answers indicate a higher probability of being infected. Questionnaires, history, and examination results are captured on-site in real time using Lynx-HCF, a comprehensive cloud-based software solution. All data related to the examination and special POC tests (HIV and Glucose) are captured in the software application using a mobile device, such as a tablet, smartphone, or a web application.

All information is stored in the EMR and is accessible by users in different roles with varying access and control levels. Comprehensive reporting and statistical analyses are provided to clients and funders, as all information is digitally captured and hosted in the cloud. Screening is taking place in selected areas all over South Africa, and to date, 150 000 people have undergone HIV and Wellness screenings, with many more over the coming months.

“With accessibility to healthcare technology being limited in underserved communities, we decided to develop an application which can accurately and easily capture information whilst in the field. The world is moving away from paper, and we are excited to be part of the journey”, says Dr Gerhard Ferreira, CEO of Healthcare Framework.

 

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version